A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Condition: Primary Immune Thrombocytopenia (ITP) Interventions: Biological: efgartigimod; Other: Placebo Sponsor: argenx BVBA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials